RecruitingNot applicableNCT02986516
Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease
Studying Chordoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Italian Sarcoma Group
- Principal Investigator
- Alessandro Gronchi, MDIstituto Nazionale Tumori Milan-Italy
- Intervention
- Randomized Cohort(other)
- Enrollment
- 100 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2017 – 2026
Study locations (28)
- Medical University of Graz, Graz, Austria
- EBG GmbH MedAustron, Wiener Neustadt, Österreich, Austria
- Medical Faculty Carl Gustav Carus Faculty of Medicine, Department of Radiation Oncology,, Dresden, Germany
- University Hospital Carl Gustav Carus Dresden, Dresden, Germany
- University Hospital Essen. West German Proton Therapy Center Essen, Essen, Germany
- Heidelberg Ion-Beam Therapy Center - HIT, Heidelberg, Germany
- National Center for Spinal Disorders, Budapest, Hungary
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, MI, Italy
- Istituto Ortopedico Rizzoli, Bologna, Italy
- Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
- Istituto Clinico Humanitas, Milan, Italy
- I.R.C.C.S. Istituto Ortopedico Galeazzi, Milan, Italy
- Centro Nazionale di Adroterapia Oncologica - CNAO, Pavia, Italy
- II Clinica Universitaria Ortopedia e Traumatologia AO Pisa, Pisa, Italy
- Istituto Regina Elena - IFO, Rome, Italy
- +13 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02986516 on ClinicalTrials.govOther trials for Chordoma
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06957327A Study of ERAS-601 in People With ChordomaMemorial Sloan Kettering Cancer Center
- ACTIVE NOT RECRUITINGPHASE2NCT06787664A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic ChordomaSichuan Baili Pharmaceutical Co., Ltd.
- RECRUITINGPHASE2NCT06794645Pembrolizumab and Pemetrexed for Progressive ChordomaSaint John's Cancer Institute
- RECRUITINGNCT06463262Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral ChordomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- RECRUITINGNANCT06029218Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton TherapyCentre Antoine Lacassagne
- ACTIVE NOT RECRUITINGPHASE2NCT05041127Cetuximab for the Treatment of Advanced Unresectable or Metastatic ChordomaM.D. Anderson Cancer Center
- RECRUITINGNCT05888064Multi-parametric Imaging in Personalized RadiotherapyCNAO National Center of Oncological Hadrontherapy
- RECRUITINGNCT04832620Image Assisted Optimization of Proton Radiation Therapy in Chordomas and ChondrosarcomasLeiden University Medical Center